Founded in 1989, Masimo Corporation, the innovator of
motion and low perfusion tolerant pulse oximetry, is a privately held
medical technology company that develops, licenses and markets advanced
medical signal processing technologies and products for the non-invasive
monitoring of patient vital signs.
Masimo Signal Extraction Technology pulse oximetry, Masimo SET®,
represents a fundamental departure from conventional pulse oximetry
technologies. Over 50 independent published studies have demonstrated that
Masimo SET substantially overcomes the limitations of conventional pulse
oximeters in accurately measuring arterial blood oxygen saturation levels
and pulse rates in the presence of patient movement and low perfusion. To
date, Masimo has licensed its Signal Extraction pulse oximetry technology
to over 35 international patient monitoring systems providers, which make
up over 60% of the world's pulse oximeter shipments.
Siemens Medical Solutions (Med) of Siemens AG (NYSE: SI) with headquarters in Iselin, NJ, and Erlangen, Germany, is one of the largest suppliers of healthcare equipment in the world. Med is renowned for its innovative products, services and complete solutions, ranging from imaging systems for diagnosis and therapy equipment for treatment, to electromedicine and hearing instruments to IT solutions that optimize workflow and increase efficiency in hospitals, clinics and doctors' offices. Siemens also offers a variety of data management solutions for customers and is currently the largest Application Service Provider. Siemens Medical Solutions, Inc. employees approximately 30,000 people worldwide.
Based in Danvers, Mass. and Solna, Sweden, the Electromedical Systems Division of Siemens Medical Solutions is a world leader in the provision of life support, anesthesia and patient monitoring systems that can be integrated to create a continuous care system throughout a healthcare facility. More information can be obtained through the company's website